News
Should hospitalists use albumin to treat non-SBP infections in patients with cirrhosis?
September 22, 2021
Study data suggest that albumin may be beneficial in improving renal and circulatory function.
News
Nurses ‘at the breaking point,’ consider quitting due to COVID issues: Survey
September 21, 2021
“What we’re hearing from our nurses is really shocking.”
![1]()
News
Decline in child COVID may signal end of latest surge
September 21, 2021
United States saw fewer cases and fewer admissions among children, but also fewer vaccinations.
News
Nurses ‘at the breaking point,’ consider quitting due to COVID issues: Survey
September 21, 2021
“Hospitals can have all the beds and all the rooms and all the equipment they want, but without nurses and others at the front lines to provide that essential care, none of it really matters.”
![1]()
News
Refined heart rate cutoffs may improve prognostic value of acute PE scoring systems
September 21, 2021
In an observational registry-based study, dropping the 110-bpm heart rate threshold improved sensitivity for low-risk PE, while increasing it improved specificity for intermediate-high–risk PE.
News
COVID-19 claims more than 675,000 U.S. lives, surpassing the 1918 flu
September 21, 2021
In some ways, the United States has failed to learn from the mistakes of the past.
![1]()
News
EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinition
September 20, 2021
Cardiologists have long defined heart failure as involving reduced or preserved ejection fraction. Results from big empagliflozin trials say forget that.
News
Moderna vaccine more effective than Pfizer and J&J
September 20, 2021
“Understanding differences in [vaccine effectiveness] by vaccine product can guide individual choices and policy recommendations regarding vaccine boosters.”
News
COVID vaccine is safe, effective for children aged 5-11, Pfizer says
September 20, 2021
A lower dose of the vaccine – just 10 mg – has been tested in children between the ages of 5 and 11.
News
FDA panel backs Pfizer’s COVID booster for 65 and older, those at high risk
September 17, 2021
This followed an earlier 16-2 vote by the panel rejecting a booster dose for Americans age 16 and over.
